David S Ziegler

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

A. Drilon, G. Demetri, S. Kummar, 2023, Cancer.

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

K. Matthay, M. Hogarty, M. Haber, 2024, British journal of cancer.